BALA CYNWYD, Pa., Sept.

SILVER SPRING, Md., July 8 /PRNewswire-USNewswire/ -- Did you know the Food and Drug Administration (FDA) continues to review vaccine safety even after a vaccine is approved? (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Learn more when FDA's Center for Biologics Evaluation and Research hosts a 30-minute webinar on the agency's efforts to ensure the safety of vaccines.

PHILADELPHIA, March 15 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), a leading provider of centralized services to global pharmaceutical, biotechnology and medical device companies, announces a pioneering electronic self-rated version of the Columbia Suicide Severity Rating Scale (C-SSRS) to facilitate compliance with regulatory requirements for prospective monitoring of suicidal ideation and behaviors.

SILVER SPRING, Md., Jan. 8 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has awarded a contract to Harvard Pilgrim Health Care Inc.

LONDON, Oct. 12 /PRNewswire/ -- Although cost efficiency is a major factor motivating pharmaceutical and biotechnology firms to outsource research, there is an increased emphasis on expertise and capabilities with the focus being on quality management.